Post by Andrea Tapparo

The efficient delivery of drugs from DPI formulations is related to the complex interaction between the OINDP inhalation device, drug formulations and patient’s inspiratory forces. I will be pleased to attend Drug Delivery to the Lungs Conference (DDL) in Edinburgh to show how we can address challenges related to inhalable powders designing with our partners an integrated strategy for particle technology. Microsphere is a trusted partner for the development and GMP manufacturing of dry powder formulations to ensure the desired aerodynamic properties of therapeutic agents directly to the lungs. Thanks to our strong technical experience in our facility in Switzerland, we are equipped also to perform optimization and control of the main critical features on site with an end-to-end control.   Let's shape together the activities needed for the clinical phases up to commercialization. Our platform is suitable also to handle poorly soluble APIs and overcome the main challenges coming from the majority of NCE and a relevant percentage of the existing ones. See you in Edinburgh, booth 156: feel free to schedule a meeting with me and Daniela. #COPD #CF #PDDS #FPF #PSD #ParticleEngineering Thanks Nikki Coates Sheila Coates

Video Content